SHERIDAN, WYOMING – May 19, 2025 – Royal Philips has announced the European launch of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter, marking a significant step in transforming structural heart procedures through minimally invasive, real-time imaging technology. Already established in the U.S. market, this cutting-edge device supports more efficient, patient-friendly interventions without requiring general anesthesia — a major development for healthcare providers facing rising demands in structural heart disease care.

Revolutionizing Intracardiac Imaging and Clinical Workflows

VeriSight Pro introduces a miniaturized ultrasound probe at the tip of a steerable catheter, just 3 millimeters in diameter, enabling detailed 2D and 3D imaging directly inside the heart. This innovation allows physicians to perform complex interventions with increased confidence, streamlined workflows, and reduced procedural burden.

SHERIDAN, WYOMING – May 19, 2025 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the successful pricing of a €1 billion dual-tranche bond issuance under its European Medium Term Note (EMTN) program, marking a strategic step to reinforce its capital structure and advance sustainable investment goals.

The offering consists of €500 million in fixed-rate notes due 2030 and another €500 million in notes due 2035. This financial move is designed to refinance existing 2026 debt maturities and fund eligible green projects as defined in the company’s Sustainable Finance Framework. With significant investor interest, both tranches were heavily oversubscribed—by more than three times for the 2030 notes and more than four times for the 2035 notes—underscoring strong market confidence in Philips’ long-term strategy and ESG commitments.

Strategic Financial Optimization with ESG Integration

SHERIDAN, WYOMING – May 19, 2025 – Teleste has announced the launch of the Luminato X32, a compact, high-performance Edge QAM solution that is set to transform how network operators deliver broadcast television in diverse environments. Designed for maximum efficiency and flexibility, the Luminato X32 provides a scalable, cost-effective way to distribute high-quality TV signals at the network edge—enhancing service reliability while reducing operational costs.

Future-Proofing Broadcast Delivery at the Network Edge

SHERIDAN, WYOMING – May 18, 2025 – In a move poised to reshape the regional dynamics of the furniture hardware sector, Hettich and FGV have officially launched Hettich Vietnam, their first joint subsidiary. This strategic initiative reflects both companies’ commitment to long-term growth in Southeast Asia and underscores their shared vision of delivering innovative, localized solutions to the fast-expanding Vietnamese furniture industry.

Strategic Expansion Targets Southeast Asia’s Growth Potential

The launch of Hettich Vietnam marks a significant milestone for the two family-owned companies as they consolidate their global partnership. Recognizing Vietnam's rapid urbanization and increasing demand for premium interior solutions, the new subsidiary is positioned to deliver tailored, high-quality products while embedding both companies more deeply within the regional value chain.

SHERIDAN, WYOMING – May 17, 2025 – Danaher Corporation has achieved a historic milestone in genomic medicine, enabling the development and delivery of the world’s first personalized mRNA-based CRISPR therapy for an infant with a life-threatening genetic disorder—in under six months. Powered by the Danaher Business System (DBS), this breakthrough exemplifies how disciplined innovation and cross-company collaboration can dramatically accelerate biopharmaceutical timelines and patient impact.

Compressing an 18-Month Timeline into Six

The urgency was real: an infant diagnosed with neonatal-onset CPS1 deficiency—a rare urea cycle disorder causing fatal ammonia accumulation—needed a cure in weeks, not years. DBS, Danaher’s proprietary system of operational tools and methodologies, allowed teams to strip away inefficiencies and take bold, calculated action.

SHERIDAN, WYOMING – May 17, 2025 – Danaher Corporation is reinforcing its position at the forefront of life sciences and diagnostics innovation through its Beacon program—an initiative designed to transform cutting-edge academic research into scalable, market-ready solutions. Spearheaded by Vanessa Almendro, PhD, MBA, Vice President, Head of Science and Technology Innovation at Danaher, the Beacon model exemplifies how strategic academic-industry collaboration can generate high-impact innovations aligned with real-world healthcare and biotechnology challenges.

A Structured Pathway from Discovery to Deployment

SHERIDAN, WYOMING – May 17, 2025 – Despite facing one of the most turbulent periods since the biotech industry’s inception in the 1970s, Danaher’s Chief Science Officer, Jose-Carlos Gutierrez-Ramos, believes the sector stands on the cusp of unprecedented progress. In a new commentary, Gutierrez-Ramos outlines why the healthcare and life sciences industries should remain optimistic, citing the explosive growth of GLP-1 receptor agonists, a rapidly evolving pipeline in Alzheimer’s research, and the transformative power of artificial intelligence.

GLP-1 Receptor Agonists Redefine Market Potential

One of the most significant advances highlighted is the rise of GLP-1 receptor agonists—initially developed for type II diabetes and now expanding rapidly into other indications. These therapies have gained broad consumer attention for their role in weight loss and obesity management, but their potential extends much further.

SHERIDAN, WYOMING – May 17, 2025 – Danaher Corporation is spotlighting the rapid progress and growing potential of RNA medicines, reaffirming its strategic commitment to genomic innovation while calling on industry stakeholders to sustain investment in the field. As RNA therapeutics expand across disease areas and delivery methods, Danaher’s leadership is urging the life sciences ecosystem to double down on momentum at what it describes as a defining moment for RNA-based medicine.

Breakthroughs in RNA Delivery and Safety Optimization

Among the most critical hurdles in RNA medicine—targeted delivery and toxicity—significant strides have been made. Lipid nanoparticle (LNP) technology has advanced in both in vivo and in vitro applications, bringing the field closer to achieving cell-type-specific delivery of therapeutic RNA molecules. This innovation promises enhanced safety and efficacy across a range of diseases.

SHERIDAN, WYOMING – Mai 15, 2025 – As the game development industry faces mounting technical, creative, and geopolitical challenges, the devcom developer conference 2025 (#ddc2025) is positioning itself as a mission-critical event for studios worldwide. With a compelling lineup of keynotes, postmortems, and practical sessions, devcom 2025 returns to Cologne’s Confex Centre from August 17–19 with a hybrid format and an agenda sharply focused on resilience, innovation, and cross-border collaboration.

Postmortem of S.T.A.L.K.E.R. 2 Sets a Raw, Real-World Tone

Headlining the speaker announcements is a powerful keynote by Ievgen Grygorovych and Mariia Grygorovych of GSC Game World. In an unprecedented live session, the duo will present a postmortem of S.T.A.L.K.E.R. 2: Heart of Chornobyl, highlighting the team’s extraordinary development journey amid war, cyberattacks, relocation, and studio destruction.

SHERIDAN, WYOMING – May 15, 2025 – With healthcare leaders calling for a fundamental strategic reorientation, the two-day Gesundheitskongress des Westens in Cologne concluded with a clear message: Germany must stop treating its healthcare system merely as a financial burden and start leveraging it as a growth catalyst.

“Healthcare is a strategic field of the future – one with the potential to invigorate our economy, unleash innovation, and reposition Germany competitively on the global stage,” said Claudia Küng, Congress Director. In light of international developments—such as the showcased digital progress from a Chinese delegation—Germany is urged to adopt a bold, clear national strategy to unlock healthcare’s full potential.

Digital Transformation Gains Ground with Electronic Patient Records